BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 6941374)

  • 21. Pharmacokinetics of amiloride after inhalation and oral administration in adolescents and adults with cystic fibrosis.
    Jones KM; Liao E; Hohneker K; Turpin S; Henry MM; Selinger K; Hsyu PH; Boucher RC; Knowles MR; Dukes GE
    Pharmacotherapy; 1997; 17(2):263-70. PubMed ID: 9085317
    [TBL] [Abstract][Full Text] [Related]  

  • 22. First human exposure to exogenous single-dose oral estetrol in early postmenopausal women.
    Visser M; Holinka CF; Coelingh Bennink HJ
    Climacteric; 2008; 11 Suppl 1():31-40. PubMed ID: 18464021
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetic and pharmacodynamic assessments of the dipeptidyl peptidase-4 inhibitor PHX1149: double-blind, placebo-controlled, single- and multiple-dose studies in healthy subjects.
    O'Farrell AM; van Vliet A; Abou Farha K; Cherrington JM; Campbell DA; Li X; Hanway D; Li J; Guler HP
    Clin Ther; 2007 Aug; 29(8):1692-705. PubMed ID: 17919550
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Single-dose pharmacokinetic study of 13-cis-retinoic acid in man.
    Besner JG; Leclaire R; Band P; Meloche S; Deschamps M; Mailhot S; Moisan R; Diorio G
    Cancer Treat Rep; 1985 Mar; 69(3):275-7. PubMed ID: 3856478
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antimuscarinic compounds and gastric kinetics: a study with pirenzepine on healthy subjects.
    Rinetti M; Ugolotti G; Ferretti PP; Colombi Zinelli L; Alberti R
    Int J Clin Pharmacol Res; 1984; 4(2):145-8. PubMed ID: 6547929
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Correlations between the pharmacokinetic indices of the tranquilizer fenazepam in single and long-term administration to patients].
    Zherdev VP; AleksandrovskiÄ­ IuA; Neznamov GG; Rudenko GM; Antokhin EA
    Farmakol Toksikol; 1987; 50(1):81-5. PubMed ID: 3556559
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The pharmacokinetic profile of pirenzepine.
    Hammer R; Koss FW
    Scand J Gastroenterol Suppl; 1979; 57():1-6. PubMed ID: 295516
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetic and clinical studies on pirenzepine, a new antiulcer drug.
    Scand J Gastroenterol Suppl; 1979; 57():1-70. PubMed ID: 295517
    [No Abstract]   [Full Text] [Related]  

  • 29. Absorption and disposition kinetics of cromolyn sodium and the influence of inhalation technique.
    Richards R; Dickson CR; Renwick AG; Lewis RA; Holgate ST
    J Pharmacol Exp Ther; 1987 Jun; 241(3):1028-32. PubMed ID: 3110405
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oxatomide plasma levels in man during chronic dosing.
    Davies BH; Rocchiccioli K
    Pharmatherapeutica; 1983; 3(6):365-9. PubMed ID: 6137831
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Advances in basic and clinical pharmacology of pirenzepine. Proceedings of the Second International Symposium on Pirenzepine. Hamburg, FRG, 8 June 1980.
    Scand J Gastroenterol Suppl; 1980; 66():1-114. PubMed ID: 6941371
    [No Abstract]   [Full Text] [Related]  

  • 32. Plasma and biliary disposition of pirenzepine in man.
    Lee SP; Paxton JW; Choong YS
    Clin Exp Pharmacol Physiol; 1986 Mar; 13(3):241-8. PubMed ID: 3087665
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Determination of nuvenzepine in human plasma by a sensitive [3H]pirenzepine radioreceptor binding assay.
    Caselli G; Ferrari MP; Tonon G; Clavenna G; Borsa M
    J Pharm Sci; 1991 Feb; 80(2):173-7. PubMed ID: 2051325
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Terazosin kinetics after oral and intravenous doses.
    Patterson SE
    Clin Pharmacol Ther; 1985 Oct; 38(4):423-7. PubMed ID: 4042526
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Single and repeated dose kinetics of the hypnotic agent loprazolam in healthy volunteers.
    Stevens LA; Bevan CD; Salmon J; Krieger J; Perianu M; LeGo A
    Eur J Clin Pharmacol; 1983; 25(5):651-5. PubMed ID: 6319150
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetic profiles of clonazepam in dog and humans and of flunitrazepam in dog.
    Kaplan SA; Alexander K; Jack ML; Puglisi CV; De Silva JA; Lee TL; Weinfeld RE
    J Pharm Sci; 1974 Apr; 63(4):527-32. PubMed ID: 4828698
    [No Abstract]   [Full Text] [Related]  

  • 37. [Anti-ulcer agent pirenzepine (LS 519)--a tricyclic compound with particular physico-chemical properties (author's transl)].
    Eberlein W; Schmidt G; Reuter A; Kutter E
    Arzneimittelforschung; 1977 Feb; 27(2):356-9. PubMed ID: 577153
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Pirenzepine parenterally administered in high doses in the treatment of upper digestive hemorrhage].
    Chirletti P; Colobraro P; Romano R; Barzi A; Mangialardi N; Bertoldi I; Valentini P; Cirenei A
    Minerva Med; 1984 Jan; 75(1-2):17-22. PubMed ID: 6607432
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Kinetics of oral trifluoperazine disposition in man.
    Midha KK; Korchinski ED; Verbeeck RK; Roscoe RM; Hawes EM; Cooper JK; McKay G
    Br J Clin Pharmacol; 1983 Mar; 15(3):380-2. PubMed ID: 6849769
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assay and pharmacokinetics of clonazepam in humans.
    Naestoft J; Lund M; Larsen NE; Hvidberg E
    Acta Neurol Scand Suppl; 1973; 53():103-8. PubMed ID: 4519452
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.